These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31799650)

  • 1. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma.
    Wang W; Chen LC; Qian JY; Zhang Q
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-1231 enhances docetaxel sensitivity to gallbladder carcinoma cells by downregulating FOXC2.
    Gong YQ; Ni JL; Fang Q; Li T
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12116-12123. PubMed ID: 33336729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
    Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB
    Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircCPA4 Promotes the Malignant Phenotypes in Glioma via miR-760/MEF2D Axis.
    Zhang Y; Cai Z; Liang J; Chai E; Lu A; Shang Y
    Neurochem Res; 2020 Dec; 45(12):2903-2913. PubMed ID: 33068224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
    Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression.
    Song L; Li D; Zhao Y; Gu Y; Zhao D; Li X; Bai X; Sun Y; Zhang X; Sun H; Wang Y; Peng L
    Tumour Biol; 2016 Mar; 37(3):2891-900. PubMed ID: 26409449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
    Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
    Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
    Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
    Zhang X; Zhang L; Chen M; Liu D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
    Cai J; Xu L; Cai Z; Wang J; Zhou B; Hu H
    Mol Med Rep; 2015 Jul; 12(1):1549-55. PubMed ID: 25760482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.
    Jiang ZB; Ma BQ; Feng Z; Liu SG; Gao P; Yan HT
    Cell Cycle; 2021 Feb; 20(3):308-319. PubMed ID: 33459111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-197 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by targeting insulin-like growth factor-binding protein 3.
    Tong L; Cheng J; Zuo H; Li J
    Adv Clin Exp Med; 2021 Jul; 30(7):661-672. PubMed ID: 34118139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.